The Baylor College of Medicine Board of Trustees has appointed Eric Mullins as its newest member of the board.
Mullins is a founder and co-chief executive officer of Lime Rock Resources, a private equity fund focused on acquiring and developing oil and gas properties.
Prior to starting Lime Rock Resources, Mullins was managing director with Goldman Sachs in the Natural Resources Group. He first worked at the firm as a summer associate in 1989 and then joined full-time as a corporate finance associate in New York. He later moved to the Energy and Power Group where he remained for the rest of his career at Goldman Sachs. He was promoted to vice president in 1994 and transferred to the Houston office in 1995. He was named a managing director in 1999. Mullins’ area of specialization was oil and gas related mergers and acquisitions and oil and gas related equity and debt financings.
A graduate of Houston’s Strake Jesuit College Preparatory high school, Mullins received a Bachelor of Arts degree from Stanford University. He received his M.B.A. from the Wharton School of the University of Pennsylvania in 1990.
He serves on the board of directors for Anadarko Petroleum Corp., where he also is chairman of the audit committee. He also is on the advisory board for the Houston chapter of the Wharton Alumni Club.
In addition to the appointment of Mullins, the Baylor College of Medicine Board of Trustees approved several significant faculty appointments:
Dr. Lea Steele was appointed as the Beth K. and Stuart C. Yudofsky Chair in Behavioral Neuroscience in the Menninger Department of Psychiatry and Behavioral Sciences. She joined Baylor College of Medicine from the Institute of Biomedical Studies at Baylor University. Steele is one of the leading experts on the long-term health consequences of military service, particularly service in the Gulf War.
Dr. David Rowley was appointed to a Duncan Professorship in the Dan L Duncan Comprehensive Cancer Center. Rowley, a professor of molecular and cellular biology, has focused on prostate cancer research for more than 25 years and is a respected educator and mentor to medical and graduate students, both at the bench and in the classroom.
Dr. Jin Wang was awarded the Jack L. Titus Professorship in Pathology. He is a leading scientist in the research of apoptosis and autophagy in the immune system, including making a groundbreaking discovery in the mechanisms for immunological memory that opened a new avenue for targeting the molecular pathways regulating autophagy to boost the efficacy of vaccination against infections.
Dr. Anthony Means, a professor of molecular and cellular biology, was appointed as Baylor College of Medicine Distinguished Service Professor. Means is a pre-eminent biomedical scientist who studies how calcium/calmodulin participates in the regulation of cell function. He also is a leader in graduate education, serving as a mentor to students as well as to his faculty colleagues.